PCM
Polaris Capital Management’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36M | Sell |
324,900
-34,800
| -10% | -$3.86M | 2.4% | 11 |
|
2025
Q1 | $40.3M | Sell |
359,700
-57,900
| -14% | -$6.49M | 2.3% | 10 |
|
2024
Q4 | $38.6M | Sell |
417,600
-10,700
| -2% | -$988K | 1.86% | 20 |
|
2024
Q3 | $35.9M | Buy |
428,300
+6,400
| +2% | +$537K | 1.77% | 24 |
|
2024
Q2 | $28.9M | Buy |
421,900
+28,700
| +7% | +$1.97M | 1.55% | 33 |
|
2024
Q1 | $28.8M | Sell |
393,200
-42,500
| -10% | -$3.11M | 1.44% | 36 |
|
2023
Q4 | $35.3M | Sell |
435,700
-11,100
| -2% | -$899K | 1.7% | 32 |
|
2023
Q3 | $33.5M | Sell |
446,800
-194,700
| -30% | -$14.6M | 1.8% | 26 |
|
2023
Q2 | $49.4M | Sell |
641,500
-19,600
| -3% | -$1.51M | 1.86% | 26 |
|
2023
Q1 | $54.9M | Sell |
661,100
-300
| -0% | -$24.9K | 2.05% | 14 |
|
2022
Q4 | $56.8M | Buy |
661,400
+9,600
| +1% | +$824K | 1.98% | 17 |
|
2022
Q3 | $40.2M | Buy |
+651,800
| New | +$40.2M | 1.58% | 28 |
|